Scope Fluidics Spolka Akcyjna (WAR:SCP) ROCE % : -32.03% (As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Scope Fluidics Spolka Akcyjna ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Scope Fluidics Spolka Akcyjna's annualized ROCE % for the quarter that ended in Sep. 2024 was -32.03%.

Scope Fluidics Spolka Akcyjna ROCE % Historical Data

The historical data trend for Scope Fluidics Spolka Akcyjna's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scope Fluidics Spolka Akcyjna ROCE % Chart

Scope Fluidics Spolka Akcyjna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

-37.65

-34.98

-32.96

216.78

-8.42

Scope Fluidics Spolka Akcyjna Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-23.07	-35.70	-28.41	-30.78	-32.03

Scope Fluidics Spolka Akcyjna ROCE % Calculation

Scope Fluidics Spolka Akcyjna's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-18.378	/	( ( (346.155 - 4.949)	+	(101.489 - 6.151) )	/ 2 )
	=	-18.378	/	( (341.206	+	95.338)	/ 2 )
	=	-18.378	/	218.272
	=	-8.42 %

Scope Fluidics Spolka Akcyjna's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-24.644	/	( ( (86.912 - 6.63)	+	(79.535 - 5.96) )	/ 2 )
	=	-24.644	/	( ( 80.282	+	73.575 )	/ 2 )
	=	-24.644	/	76.9285
	=	-32.03 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Scope Fluidics Spolka Akcyjna (WAR:SCP) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Scope Fluidics Spolka Akcyjna ROCE % Related Terms

Thank you for viewing the detailed overview of Scope Fluidics Spolka Akcyjna's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Scope Fluidics Spolka Akcyjna Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Scope Fluidics Spolka Akcyjna (WAR:SCP) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

S84:Germany

Address

Duchnicka 3, Build 16, Entrance A, Warsaw, POL, 01-796

Website

http://www.scopefluidics.com

Scope Fluidics Spolka Akcyjna focuses on global challenges in health to develop diagnostic and med tech solutions. The company combines the expertise in microfluidic technology with the awareness of the challenges in medical diagnostics. It provides prototyping support for diagnostic services.

Scope Fluidics Spolka Akcyjna Headlines

No Headlines